Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Navigating IT change management within the regulated pharmaceutical sector involves a meticulous approach to ensure compliance, data integrity, and system effectiveness. This blog explores steps, key strategies, challenges and best practices to master this complex process.
Medical device complaints? Don't sweat it! They can actually be a goldmine for improvement. An effective complaint handling system safeguards patients by identifying and addressing potential risks. It also helps improve devices by providing valuable data for future iterations. Plus,
Discover the essential guide to navigating notified body inspections for medical devices with our 10 easy steps. Ensure compliance, streamline the process, and achieve success with expert insights and actionable strategies.
Complaint handling is an integral part of medical device companies’ Quality Management System (QMS). It involves receiving, investigating, and resolving customer complaints related to medical device products and services provided by an organization. Such complaints are related to the safety,
The FDA’s Bioresearch Monitoring Program (BIMO) is critical for maintaining the integrity of clinical trials. In this blog, we explore the nuances of BIMO inspections and offer detailed guidance for clinical researchers to navigate these complex evaluations.
Validation software is a game-changer for the pharmaceutical industry. This blog explores how it enhances compliance, efficiency, and product safety, ensuring top-notch quality and regulatory adherence.
Understanding FDA inspections is crucial for businesses in the food & drug industry. This blog breaks down the different types of inspections, the post-inspection process, and how to be prepared for a smooth FDA visit.
For medical devices, where minor flaws endanger lives, a strong supply chain risk plan is essential. It prioritizes patient safety by mitigating risks like faulty parts or counterfeits and shows compliance with regulations.
21 CFR 211 compliance is your organization's stepping stone to meeting the FDA's definition of current good manufacturing practice (cGMP). Complying with 21 CFR 211 proves that your business has a safe, effective, consistent and quality-managed drug manufacturing operation in
Unlock the secrets of regulatory compliance comparison of EU Annex11 and 21CFR Part 11! These guidelines differ in scope and requirements, ensuring your computerized systems meet the highest standards in pharmaceutical and life sciences.